Community pharmacists' attitudes towards clinical utility and ethical implications of pharmacogenetic testing.
about
Bringing clinical pharmacogenomics information to pharmacists: A qualitative study of information needs and resource requirements.Examining perceptions of the usefulness and usability of a mobile-based system for pharmacogenomics clinical decision support: a mixed methods study.Advancing Pharmacogenomics Education in the Core PharmD Curriculum through Student Personal Genomic Testing.The 3-I framework: a framework for developing public policies regarding pharmacogenomics (PGx) testing in Canada.Educational strategies to enable expansion of pharmacogenomics-based care.Proposal for a pharmacogenetics certificate program for pharmacists.Pharmacogenetics in Cardiovascular Medicine.Opinions, hopes and concerns regarding pharmacogenomics: a comparison of healthy individuals, heart failure patients and heart transplant recipients.Multisite Investigation of Strategies for the Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy.Developing Pharmacogenomic Reports: Insights from Patients and Clinicians.Design and evaluation of a pharmacogenomics information resource for pharmacists.Pharmacogenomics testing in a community pharmacy: patient perceptions and willingness-to-pay.Pharmacogenomics: From classroom to practice.Knowledge, perceptions and confidence of physicians and pharmacists towards pharmacogenetics practice in KuwaitAn Effective Approach to Teaching Pharmacogenomics in the First Year of Pharmacy Curriculum
P2860
Q30699715-AE4440D9-0938-49FA-9BF2-C3F2B82B3271Q36623055-FC353C43-552B-4489-9664-7A78586A9330Q36645837-80121BA0-DF66-4336-AF0F-834544F88556Q38654780-0802E475-37B9-4755-B663-F581E2B5846EQ39173293-1138B82B-222E-4135-8E8F-0B9CA47F2874Q41430267-08704DD0-1C60-41E8-8B67-676F3D39AA8FQ47130405-EE7B9BCE-A708-4831-ADD1-9A828240AFB6Q47592664-D7B846B5-731B-4BE7-8E58-A79720F347D2Q48345994-81521B34-9665-478C-BCEB-1793448538A4Q50117218-183CDF89-BA2D-4EFE-A507-18DE601583F8Q50775977-8FD3931A-1E30-4BB1-842B-43FF1783B8F2Q53672069-D35A09D4-4B22-4DB0-8FF4-12972B73B06BQ55429432-2666414B-E942-43F1-B1CE-08F2A30D96ABQ57160932-2D39A69F-94B3-4F79-8EFD-D5C96E4D99F1Q58697671-A785B76E-763F-4E75-8379-10591E27E0BA
P2860
Community pharmacists' attitudes towards clinical utility and ethical implications of pharmacogenetic testing.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Community pharmacists' attitud ...... ns of pharmacogenetic testing.
@en
Community pharmacists' attitud ...... ns of pharmacogenetic testing.
@nl
type
label
Community pharmacists' attitud ...... ns of pharmacogenetic testing.
@en
Community pharmacists' attitud ...... ns of pharmacogenetic testing.
@nl
prefLabel
Community pharmacists' attitud ...... ns of pharmacogenetic testing.
@en
Community pharmacists' attitud ...... ns of pharmacogenetic testing.
@nl
P2093
P2860
P356
P1476
Community pharmacists' attitud ...... ns of pharmacogenetic testing.
@en
P2093
Barbara Bernhardt
Cara Zayac
Jon E Sprague
Kevin Haynes
Reed Pyeritz
P2860
P356
10.2217/PME.13.85
P407
P50
P577
2013-11-01T00:00:00Z